FDA
-
-
-
-
-
-
-
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
-
-
-
-
-
-
-
BioSig Technologies (BSGM) Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
-
-
-
-
-
-
-
BioSig Technologies (BSGM) Announces Reduction of its Workforce
-
-
-
-
-
-
-
BioSig Technologies (BSGM) plans workforce reduction, shifts its core strategy
-
-
-
-
-
-
-
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
-
-
-
-
-
-
-
BioSig Technologies (BSGM) Joins Webull Corporate Connect
-
322,091 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

